GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,646.50
Bid: 1,646.00
Ask: 1,646.50
Change: -4.00 (-0.24%)
Spread: 0.50 (0.03%)
Open: 1,650.50
High: 1,658.50
Low: 1,642.00
Prev. Close: 1,650.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: GSK execs sell shares for tax bills, Airtel director makes £50k purchase

Thu, 17th Feb 2022 16:06

(Sharecast News) - GlaxoSmithKline disclosed a number of executive awards on Thursday, with two of its directors making large sales to cover their tax bills.

The FTSE 100 pharmaceuticals giant said chief executive officer Emma Walmsley had exercised nil-cost options granted in 2019 over 72,296 shares.

To meet her tax liabilities on that exercise, she then sold 34,031 shares for 1,609.97p each, totalling £547,888.92.

At the same time, GSK's chief scientific officer and president of research and development, Hal Barron, vested an annual bonus award granted in 2019 over 43,266 American depositary shares.

For his tax liabilities, he then sold 19,936 of those ADS securities for a price of $42.95432 each, the company disclosed.

On the buying side of things, Airtel Africa reported a share purchase made by one of its directors on Thursday, worth almost £50k.

The FTSE 100 mobile network operator said Ravi Rajagopal bought 35,750 shares on the London Stock Exchange on 10 February.

It said Rajagopal paid 139.8p for each share, spending a total of £49,978.50 in the process.

Top Director Buys

Schroder Uk Mid Cap Fund (SCP)

Director name: Page,Andrew

Amount purchased: 14,000 @ 616.70p

Value: £86,338.00

Airtel Africa (AAF)

Director name: Rajagopal,Ravi

Amount purchased: 35,750 @ 139.80p

Value: £49,978.50

Heiq (HEIQ)

Director name: Centonze,Carlo Riccardo

Amount purchased: 33,000 @ 90.00p

Value: £29,700.00

Watkin Jones (WJG)

Director name: Sergeant,Sarah

Amount purchased: 9,950 @ 247.63p

Value: £24,638.84

W H Ireland Group (WHI)

Director name: Wood,Tom

Amount purchased: 44,444 @ 45.00p

Value: £19,999.80

Aex Gold Inc. Npv (di) (AEXG)

Director name: Neuhauser,David Loren

Amount purchased: 43,300 @ $0.59

Value: $15,113.89

Aex Gold Inc. Npv (di) (AEXG)

Director name: Neuhauser,David Loren

Amount purchased: 17,200 @ $0.53

Value: $5,393.13

Aex Gold Inc. Npv (di) (AEXG)

Director name: Neuhauser,David Loren

Amount purchased: 14,000 @ $0.55

Value: $4,555.41

Aex Gold Inc. Npv (di) (AEXG)

Director name: Neuhauser,David Loren

Amount purchased: 10,300 @ $0.54

Value: $3,290.54

Aex Gold Inc. Npv (di) (AEXG)

Director name: Neuhauser,David Loren

Amount purchased: 7,000 @ $0.55

Value: $2,277.70

Johnson Matthey (JMAT)

Director name: MacLeod,Robert

Amount purchased: 18 @ 1,823.84p

Value: £328.29

Victrex Plc (VCT)

Director name: Court ,Martin

Amount purchased: 8 @ 1,979.00p

Value: £158.32

Top Director Sells

Glaxosmithkline (GSK)

Director name: Barron ,Hal

Amount sold: 39,872 @ $21.48

Value: $706,122.72

Glaxosmithkline (GSK)

Director name: Walmsley,Emma

Amount sold: 34,031 @ 1,609.97p

Value: £547,888.92

More News
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.